EUVIMEDEUVIMED entdecken
Open Access

Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam

Paul C Adamson iD, Hollie M David iD, Loc Q Pham iD, Hao T M Bui iD, Hai Ha Long Le iD, Quynh Hoa Pham iD, Doanh H Le, Le Minh Giang iD, Jeffrey D Klausner iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Paul C Adamson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Cefixime, Gonorrhea, Neisseria gonorrhoeae, Anti-Bacterial Agents. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NIAID NIH HHS, US National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance in Neisseria gonorrhoeae is a global health problem. Ceftriaxone is the first-line treatment, while cefixime is recommended as an alternative. Data on cefixime treatment outcomes, particularly from areas with increased resistance, are limited.

Methods

We conducted a retrospective review of all gonococcal infections treated with cefixime 800 mg and ceftriaxone 500 mg within a sexual health program in Hanoi, Vietnam, between May 2022 and February 2023. Gonococcal infections were detected via culture or N. gonorrhoeae nucleic acid amplification testing (NAAT) at pharyngeal, rectal, or urogenital sites. A test of cure (TOC) was done 10–21 days posttreatment. Multivariate logistic regression was used to evaluate factors associated with TOC positivity.

Results

There were 24 participants treated with cefixime and 75 participants treated with ceftriaxone. The median time to follow-up testing was 12 days (range, 8–18 days) for cefixime and 17 days (range, 8–28 days) for ceftriaxone (P < .01). All follow-up cultures were negative. NAAT positivity was higher for cefixime (45.0%) compared to ceftriaxone (17.7%) (P = .014); all were positive at the pharynx, and 1 was also positive rectally. In multivariate analysis, higher initial NAAT cycle threshold values (adjusted odds ratio [aOR], 0.81 [95% confidence interval {CI}, .70–.92]) and ceftriaxone treatment (aOR, 0.11 [95% CI, .02–.61]) were associated with lower odds of positivity at TOC.

Conclusions

Among N. gonorrhoeae infections treated with oral cefixime, we found no positive cultures at follow-up. Higher NAAT positivity among those treated with cefixime could reflect slower clearance at pharyngeal sites. However, persistent detection by NAATs at pharyngeal sites suggests the presence of nonviable bacteria, a limitation of the tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefiximeGonorrheaNeisseria gonorrhoeaeAnti-Bacterial AgentsDrug Resistance, BacterialHumansRetrospective StudiesVietnamCeftriaxoneMaleFemaleAdultThird Generation CephalosporinsSecond Generation CephalosporinsTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

gonorrhea; Neisseria gonorrhoeae; antimicrobial resistance; pharyngeal gonorrhe…

Substanzen

CefiximeAnti-Bacterial AgentsCeftriaxoneThird Generation CephalosporinsSecond Generation Cephalosporins

Autor:innen und Institutionen

  • Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Center for Research and Training on Substance Abuse-HIV, Hanoi Medical University, Hanoi, Vietnam.
  • National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
  • Department of Clinical Microbiology and Parasitology, Faculty of Medical Technology, Hanoi Medical University, Hanoi, Vietnam.
  • Department of Dermatology and Venereology, Hanoi Medical University, Hanoi, Vietnam.
  • Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Paul C Adamson, Hollie M David, Loc Q Pham, Hao T M Bui, Hai Ha Long Le, Quynh Hoa Pham, Le Minh Giang, Jeffrey D Klausner

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS
  • US National Institute of Allergy and Infectious Diseases
  • Fogarty International Center

Zitieren

APA

Adamson, P. C., David, H. M., Pham, L. Q., Bui, H. T. M., Le, H. H. L., Pham, Q. H., Le, D. H., Giang, L. M., & Klausner, J. D. (2026). Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf607

Vancouver

Adamson PC, David HM, Pham LQ, Bui HTM, Le HHL, Pham QH, et al. Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf607

BibTeX
@article{Adamson2026,
  author = {Adamson, Paul C and David, Hollie M and Pham, Loc Q and Bui, Hao T M and Le, Hai Ha Long and Pham, Quynh Hoa and Le, Doanh H and Giang, Le Minh and Klausner, Jeffrey D},
  title = {Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf607}
}
Kostenlos starten →